company background image
300765 logo

CSPC Innovation Pharmaceutical SZSE:300765 Stock Report

Last Price

CN¥36.41

Market Cap

CN¥42.6b

7D

-9.2%

1Y

222.8%

Updated

26 Mar, 2024

Data

Company Financials +

CSPC Innovation Pharmaceutical Co., Ltd.

SZSE:300765 Stock Report

Market Cap: CN¥42.6b

300765 Stock Overview

CSPC Innovation Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of functional foods in the field of general health in China and internationally.

300765 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth4/6
Past Performance3/6
Financial Health6/6
Dividends3/6

CSPC Innovation Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for CSPC Innovation Pharmaceutical
Historical stock prices
Current Share PriceCN¥36.41
52 Week HighCN¥48.74
52 Week LowCN¥10.88
Beta-0.25
1 Month Change18.60%
3 Month Change0.25%
1 Year Change222.85%
3 Year Change379.73%
5 Year Change236.31%
Change since IPO407.72%

Recent News & Updates

Recent updates

Shareholder Returns

300765CN PharmaceuticalsCN Market
7D-9.2%-4.1%-2.9%
1Y222.8%-10.4%-15.4%

Return vs Industry: 300765 exceeded the CN Pharmaceuticals industry which returned -10.4% over the past year.

Return vs Market: 300765 exceeded the CN Market which returned -15.4% over the past year.

Price Volatility

Is 300765's price volatile compared to industry and market?
300765 volatility
300765 Average Weekly Movement10.5%
Pharmaceuticals Industry Average Movement6.9%
Market Average Movement8.1%
10% most volatile stocks in CN Market11.3%
10% least volatile stocks in CN Market5.1%

Stable Share Price: 300765's share price has been volatile over the past 3 months.

Volatility Over Time: 300765's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of CN stocks.

About the Company

FoundedEmployeesCEOWebsite
20061,887Feng Hanhttps://www.xnwpharma.net

CSPC Innovation Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of functional foods in the field of general health in China and internationally. It offers functional raw materials, including caffeine, acarbose, anhydrous glucose, theophylline, aminophylline, dyphylline, theobromine, pentoxifylline, doxofylline, and biological enzymes; and health food products, such as Guoweikangwei C tablets, Guoweikang B vitamin lozenges, etc. The company was founded in 2006 and is headquartered in Shijiazhuang, China. CSPC Innovation Pharmaceutical Co., Ltd.

CSPC Innovation Pharmaceutical Co., Ltd. Fundamentals Summary

How do CSPC Innovation Pharmaceutical's earnings and revenue compare to its market cap?
300765 fundamental statistics
Market capCN¥42.63b
Earnings (TTM)CN¥755.56m
Revenue (TTM)CN¥2.50b

56.4x

P/E Ratio

17.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
300765 income statement (TTM)
RevenueCN¥2.50b
Cost of RevenueCN¥1.37b
Gross ProfitCN¥1.13b
Other ExpensesCN¥377.18m
EarningsCN¥755.56m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.65
Gross Margin45.28%
Net Profit Margin30.20%
Debt/Equity Ratio0%

How did 300765 perform over the long term?

See historical performance and comparison

Dividends

0.9%

Current Dividend Yield

49%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.